These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 7041771

  • 1. Granulocyte proteases in middle ear effusions.
    Carlsson B, Lundberg C, Ohlsson K.
    Ann Otol Rhinol Laryngol; 1982; 91(1 Pt 1):76-81. PubMed ID: 7041771
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antifibrinolytic activity in middle ear effusion.
    Hamaguchi Y, Sakakura Y, Ukai K, Ohi M, Miyoshi Y.
    ORL J Otorhinolaryngol Relat Spec; 1984; 46(5):235-41. PubMed ID: 6237294
    [Abstract] [Full Text] [Related]

  • 4. Biochemical study of protease inhibitors in experimental otitis media with effusion.
    Juhn SK, Hamaguchi Y.
    Ann Otol Rhinol Laryngol Suppl; 1988; 132():10-3. PubMed ID: 2454602
    [No Abstract] [Full Text] [Related]

  • 5. Protease inhibitors in middle ear effusions.
    Carlsson B, Lundberg C, Ohlsson K.
    Ann Otol Rhinol Laryngol; 1981; 90(1 Pt 1):38-41. PubMed ID: 6162410
    [Abstract] [Full Text] [Related]

  • 6. Hydrolase activity in acute otitis media with effusion.
    Diven WF, Glew RH, LaMarco KL.
    Ann Otol Rhinol Laryngol; 1985; 94(4 Pt 1):415-8. PubMed ID: 4040728
    [Abstract] [Full Text] [Related]

  • 7. Kinetics of lysosomal protease activity in human otitis media with effusion.
    Hamaguchi Y, Sakakura Y, Majima Y, Juhn SK.
    Am J Otolaryngol; 1987; 8(4):194-8. PubMed ID: 2443031
    [Abstract] [Full Text] [Related]

  • 8. [Proteases and their inhibitors in posttraumatic knee joint effusion].
    Kunz E, Blattert TR, Weckbach A.
    Z Orthop Ihre Grenzgeb; 1996; 134(5):426-9. PubMed ID: 8967142
    [Abstract] [Full Text] [Related]

  • 9. Analysis of protease activity in human otitis media.
    Avidano MA, Cotter CS, Stringer SP, Schultz GS.
    Otolaryngol Head Neck Surg; 1998 Oct; 119(4):346-51. PubMed ID: 9781988
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of the reactions of neutral granulocyte proteases with the major plasma protease inhibitors and with antiplasmin.
    Ohlsson K, Collen D.
    Scand J Clin Lab Invest; 1977 Jun; 37(4):345-50. PubMed ID: 210494
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of granulocyte neutral proteases on complement components.
    Johnson U, Ohlsson K, Olsson I.
    Scand J Immunol; 1976 Jun; 5(4):421-6. PubMed ID: 181839
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effect of the secretory leukocyte protease inhibitor on leukocyte proteases released during phagocytosis.
    Axelsson L, Linder C, Ohlsson K, Rosengren M.
    Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():89-93. PubMed ID: 2578013
    [Abstract] [Full Text] [Related]

  • 19. Granulocyte collagenase and elastase and the plasma protease inhibitors in human pus.
    Delshammar M, Ohlsson K.
    Surgery; 1978 Mar; 83(3):323-7. PubMed ID: 204072
    [Abstract] [Full Text] [Related]

  • 20. [Activity of granulocyte proteases and their acid-resistant inhibitors in bronchial secretions of patients with tuberculosis, complicated by nonspecific endobronchitis].
    Shesterina MV, Ogloblina OG, Maliev BM.
    Probl Tuberk; 1983 Feb; (2):51-5. PubMed ID: 6341984
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.